Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news

Show

From To
The First HIV/AIDS Generation Reaches Retirement Age

People with HIV and AIDS are living longer than was ever expected before the development of highly active antiretroviral therapies in the 1990s. Palm Springs, a Coachella Valley desert city 100 miles east of Los Angeles, has become a hub for older infected residents well into their 60s and 70s. Yet even as many live longer, there is a broad segment of HIV patients who are aging physically and cognitively faster than the rest of the population.

Published
22 September 2014
From
Newsweek
Why HIV patients develop dementia

Although HIV dos not infect nerve cells, researchers strongly suspect that, once activated in the brain and the spinal cord, immune cells keep up a chronic inflammation level which then results in the destruction of nerve cells.

Published
05 September 2014
From
EATG
Efavirenz use not linked to neurocognitive impairment

People who use antiretroviral regimens containing efavirenz (Sustiva or Stocrin, also in the Atripla coformulation) were not at higher risk for impaired neurocognitive function, either overall or when looking

Published
25 July 2014
By
Liz Highleyman
Study finds no evidence that HIV-positive gay men in UK have increased risk of neurocognitive impairment

Prevalence and severity of neurocognitive impairment does not differ between HIV-positive and HIV-negative gay men, UK investigators report in the online edition of the Journal of Acquired

Published
15 July 2014
By
Michael Carter
Common HIV Drug May Boost Suicide Risk

A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends. The finding concerns the anti-HIV drug efavirenz, which is marketed as Sustiva.

Published
02 July 2014
From
Web MD
PI Therapy Raises Risk of Cerebral Small-Vessel Disease in US Group

Treatment with HIV protease inhibitors (PIs) heightened chances of cerebral small-vessel disease (CSVD) in a group of US adults. And mild CSVD raised chances of HIV-associated neurocognitive disorder (HAND).

Published
30 May 2014
From
International AIDS Society
PCR testing reveals high prevalence of CNS infections among people living with HIV in Zambia with CNS symptoms

There is a high prevalence of central nervous system (CNS) opportunistic infections among people living with HIV in Zambia who present with CNS symptoms, investigators report in

Published
30 April 2014
By
Michael Carter
New dementia adviser says thousands should be given access to experimental drugs

In an interview with The Telegraph, the World Dementia Envoy said any promising drugs should be given to “large populations” in order to speed the search for a breakthrough - as happened decades ago in the battle against HIV.

Published
24 March 2014
From
Daily Telegraph
HIV and MS: Could a Link Lead to New MS Treatment?

The integrase inhibitor raltegravir is being tested as a treatment for multiple sclerosis. Evidence from cohort studies suggests that since the introduction of HAART people living with HIV had a lower risk of developing multiple sclerosis than the general population.

Published
21 March 2014
From
MedPage Today
Study Links Fitness Level and HIV-related Dementia

A new study shows that fitness level in HIV infected individuals is related to cognitive impairment. These results suggest that something as simple as exercise may be able to stave off neurological decline in this growing segment of the aging population.

Published
16 December 2013
From
University of Rochester Medical Center
← First12345...10Next →

Filter by country